Home › Trial NCT05488626
Daily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer
- Trial IDNCT05488626
- StatusWithdrawn
- PhaseN/A
- Study typeInterventional
- SponsorVarian, a Siemens Healthineers Company
- Enrollment—
- Start date2022-10-20
- ConditionsStage III Non-small Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.